Mouillac Bernard, Sen Tuhinadri, Durroux Thierry, Gaibelet Gérald, Barberis Claude
INSERM U469, 141 rue de la Cardonille, 34094 Montpellier, France.
Prog Brain Res. 2002;139:163-77. doi: 10.1016/s0079-6123(02)39015-0.
In order to produce large amounts of human vasopressin and oxytocin receptors compatible with direct structural biology approaches such as X-ray crystallography, NMR or mass spectrometry, we have expressed these neurohypophysial hormone receptors in Escherichia coli. To facilitate the level of expression, the coding sequence for the V1a vasopressin receptor and the oxytocin receptor were first optimized for bacterial expression. The resulting 'bacterial receptor cDNAs' were then subcloned into pET/T7-driven prokaryotic expression vectors. Different constructs have been prepared: each cDNA was incorporated alone or in fusion with a T7 tag sequence or a glutathione-S-transferase tag sequence at the N-terminus end. Moreover, a 6 x His tag sequence has been added at the C-terminus end for one-step purification of the receptors. Screening of BL21(DE3) and BL21(DE3)pLysS bacterial strains transformed with the different constructions was achieved by Coomassie blue-stained SDS-polyacrylamide gels and by 6 x His antibody Western blotting. Several clones were selected for purification of the receptors. Expression levels of the receptors are now encouraging and will be optimized for further structural and functional studies. Moreover, at the same time, the construction of the bacterial-optimized sequence of the V2 vasopressin receptor and its expression will be performed.
为了大量生产与X射线晶体学、核磁共振或质谱等直接结构生物学方法兼容的人血管加压素和催产素受体,我们已在大肠杆菌中表达这些神经垂体激素受体。为提高表达水平,首先对V1a血管加压素受体和催产素受体的编码序列进行了细菌表达优化。然后将得到的“细菌受体cDNA”亚克隆到pET/T7驱动的原核表达载体中。已制备了不同的构建体:每个cDNA单独整合,或在N末端与T7标签序列或谷胱甘肽-S-转移酶标签序列融合。此外,在C末端添加了一个6×组氨酸标签序列,用于受体的一步纯化。通过考马斯亮蓝染色的SDS-聚丙烯酰胺凝胶和6×组氨酸抗体免疫印迹法对用不同构建体转化的BL21(DE3)和BL21(DE3)pLysS菌株进行筛选。选择了几个克隆用于受体的纯化。受体的表达水平目前令人鼓舞,将针对进一步的结构和功能研究进行优化。此外,与此同时,将进行V2血管加压素受体的细菌优化序列构建及其表达。